nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CCL2—type 2 diabetes mellitus	0.248	0.442	CbGaD
Danazol—SHBG—type 2 diabetes mellitus	0.141	0.251	CbGaD
Danazol—AR—type 2 diabetes mellitus	0.124	0.22	CbGaD
Danazol—CYP3A4—type 2 diabetes mellitus	0.0488	0.0867	CbGaD
Danazol—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0219	0.152	CbGbCtD
Danazol—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0195	0.136	CbGbCtD
Danazol—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0179	0.124	CbGbCtD
Danazol—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0156	0.109	CbGbCtD
Danazol—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0141	0.0982	CbGbCtD
Danazol—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0107	0.0744	CbGbCtD
Danazol—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0103	0.0714	CbGbCtD
Danazol—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0103	0.0714	CbGbCtD
Danazol—CCL2—tunica intima—type 2 diabetes mellitus	0.01	0.196	CbGeAlD
Danazol—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0097	0.0675	CbGbCtD
Danazol—CCL2—brown adipose tissue—type 2 diabetes mellitus	0.0078	0.152	CbGeAlD
Danazol—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00723	0.0503	CbGbCtD
Danazol—CYP3A4—Losartan—type 2 diabetes mellitus	0.00661	0.046	CbGbCtD
Danazol—CCL2—artery—type 2 diabetes mellitus	0.00343	0.0669	CbGeAlD
Danazol—SHBG—hindlimb—type 2 diabetes mellitus	0.00327	0.0637	CbGeAlD
Danazol—AR—penis—type 2 diabetes mellitus	0.00311	0.0605	CbGeAlD
Danazol—CCL2—endothelium—type 2 diabetes mellitus	0.0029	0.0565	CbGeAlD
Danazol—PGR—artery—type 2 diabetes mellitus	0.0018	0.0352	CbGeAlD
Danazol—CCL2—islet of Langerhans—type 2 diabetes mellitus	0.00165	0.0322	CbGeAlD
Danazol—CCL2—Irbesartan—Valsartan—type 2 diabetes mellitus	0.00159	0.54	CbGdCrCtD
Danazol—CCL2—retina—type 2 diabetes mellitus	0.00141	0.0275	CbGeAlD
Danazol—CCL2—Irbesartan—Losartan—type 2 diabetes mellitus	0.00135	0.46	CbGdCrCtD
Danazol—CCL2—nephron tubule—type 2 diabetes mellitus	0.00133	0.0259	CbGeAlD
Danazol—CCL2—cardiovascular system—type 2 diabetes mellitus	0.00119	0.0233	CbGeAlD
Danazol—CCL2—kidney—type 2 diabetes mellitus	0.00117	0.0228	CbGeAlD
Danazol—CCL2—pancreas—type 2 diabetes mellitus	0.00116	0.0226	CbGeAlD
Danazol—CCL2—cortex of kidney—type 2 diabetes mellitus	0.00114	0.0222	CbGeAlD
Danazol—CCL2—adipose tissue—type 2 diabetes mellitus	0.00105	0.0205	CbGeAlD
Danazol—Trilostane—HSD3B2—type 2 diabetes mellitus	0.000809	0.159	CrCbGaD
Danazol—CCL2—liver—type 2 diabetes mellitus	0.000738	0.0144	CbGeAlD
Danazol—SHBG—cardiovascular system—type 2 diabetes mellitus	0.000696	0.0136	CbGeAlD
Danazol—PGR—cardiovascular system—type 2 diabetes mellitus	0.000627	0.0122	CbGeAlD
Danazol—SHBG—adipose tissue—type 2 diabetes mellitus	0.000614	0.012	CbGeAlD
Danazol—PGR—adipose tissue—type 2 diabetes mellitus	0.000553	0.0108	CbGeAlD
Danazol—AR—cardiovascular system—type 2 diabetes mellitus	0.0005	0.00974	CbGeAlD
Danazol—CYP19A1—adipose tissue—type 2 diabetes mellitus	0.000498	0.0097	CbGeAlD
Danazol—Prednisone—HSD11B1—type 2 diabetes mellitus	0.000496	0.0977	CrCbGaD
Danazol—ESR1—cardiovascular system—type 2 diabetes mellitus	0.00049	0.00956	CbGeAlD
Danazol—AR—kidney—type 2 diabetes mellitus	0.000489	0.00953	CbGeAlD
Danazol—ESR1—kidney—type 2 diabetes mellitus	0.00048	0.00935	CbGeAlD
Danazol—AR—cortex of kidney—type 2 diabetes mellitus	0.000476	0.00928	CbGeAlD
Danazol—AR—adipose tissue—type 2 diabetes mellitus	0.000441	0.00859	CbGeAlD
Danazol—ESR1—adipose tissue—type 2 diabetes mellitus	0.000433	0.00843	CbGeAlD
Danazol—SHBG—liver—type 2 diabetes mellitus	0.000431	0.00839	CbGeAlD
Danazol—Levonorgestrel—SRD5A1—type 2 diabetes mellitus	0.000389	0.0766	CrCbGaD
Danazol—CYP19A1—liver—type 2 diabetes mellitus	0.000349	0.0068	CbGeAlD
Danazol—Stanozolol—AR—type 2 diabetes mellitus	0.000325	0.064	CrCbGaD
Danazol—AR—liver—type 2 diabetes mellitus	0.000309	0.00602	CbGeAlD
Danazol—ESR1—liver—type 2 diabetes mellitus	0.000303	0.00591	CbGeAlD
Danazol—Oxandrolone—AR—type 2 diabetes mellitus	0.000293	0.0576	CrCbGaD
Danazol—CYP3A4—kidney—type 2 diabetes mellitus	0.000268	0.00522	CbGeAlD
Danazol—Desogestrel—SHBG—type 2 diabetes mellitus	0.00023	0.0453	CrCbGaD
Danazol—Etonogestrel—SHBG—type 2 diabetes mellitus	0.000186	0.0366	CrCbGaD
Danazol—CYP3A4—liver—type 2 diabetes mellitus	0.000169	0.0033	CbGeAlD
Danazol—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000149	0.0011	CcSEcCtD
Danazol—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000149	0.0011	CcSEcCtD
Danazol—Nausea—Repaglinide—type 2 diabetes mellitus	0.000149	0.0011	CcSEcCtD
Danazol—Asthenia—Glipizide—type 2 diabetes mellitus	0.000149	0.0011	CcSEcCtD
Danazol—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000148	0.00109	CcSEcCtD
Danazol—Flushing—Irbesartan—type 2 diabetes mellitus	0.000148	0.00109	CcSEcCtD
Danazol—Pruritus—Glipizide—type 2 diabetes mellitus	0.000147	0.00108	CcSEcCtD
Danazol—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000147	0.00108	CcSEcCtD
Danazol—Weight increased—Ramipril—type 2 diabetes mellitus	0.000146	0.00108	CcSEcCtD
Danazol—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000145	0.00107	CcSEcCtD
Danazol—Vertigo—Valsartan—type 2 diabetes mellitus	0.000145	0.00107	CcSEcCtD
Danazol—Syncope—Valsartan—type 2 diabetes mellitus	0.000145	0.00107	CcSEcCtD
Danazol—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000143	0.00106	CcSEcCtD
Danazol—Vertigo—Orlistat—type 2 diabetes mellitus	0.000143	0.00105	CcSEcCtD
Danazol—Chills—Irbesartan—type 2 diabetes mellitus	0.000143	0.00105	CcSEcCtD
Danazol—Palpitations—Valsartan—type 2 diabetes mellitus	0.000143	0.00105	CcSEcCtD
Danazol—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000143	0.00105	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000142	0.00105	CcSEcCtD
Danazol—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000142	0.00104	CcSEcCtD
Danazol—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000142	0.00104	CcSEcCtD
Danazol—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000141	0.00104	CcSEcCtD
Danazol—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000141	0.00104	CcSEcCtD
Danazol—Palpitations—Orlistat—type 2 diabetes mellitus	0.000141	0.00104	CcSEcCtD
Danazol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000141	0.00104	CcSEcCtD
Danazol—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00014	0.00103	CcSEcCtD
Danazol—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.00014	0.00103	CcSEcCtD
Danazol—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00014	0.00103	CcSEcCtD
Danazol—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00014	0.00103	CcSEcCtD
Danazol—Jaundice—Ramipril—type 2 diabetes mellitus	0.00014	0.00103	CcSEcCtD
Danazol—Flushing—Losartan—type 2 diabetes mellitus	0.000139	0.00102	CcSEcCtD
Danazol—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000139	0.00102	CcSEcCtD
Danazol—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000139	0.00102	CcSEcCtD
Danazol—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000139	0.00102	CcSEcCtD
Danazol—Vision blurred—Metformin—type 2 diabetes mellitus	0.000138	0.00102	CcSEcCtD
Danazol—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000138	0.00102	CcSEcCtD
Danazol—Convulsion—Orlistat—type 2 diabetes mellitus	0.000138	0.00102	CcSEcCtD
Danazol—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000138	0.00102	CcSEcCtD
Danazol—Tremor—Metformin—type 2 diabetes mellitus	0.000138	0.00101	CcSEcCtD
Danazol—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000137	0.00101	CcSEcCtD
Danazol—Sweating—Ramipril—type 2 diabetes mellitus	0.000137	0.00101	CcSEcCtD
Danazol—Dizziness—Glipizide—type 2 diabetes mellitus	0.000137	0.00101	CcSEcCtD
Danazol—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000137	0.00101	CcSEcCtD
Danazol—Anxiety—Valsartan—type 2 diabetes mellitus	0.000137	0.00101	CcSEcCtD
Danazol—Tension—Irbesartan—type 2 diabetes mellitus	0.000136	0.001	CcSEcCtD
Danazol—Anxiety—Orlistat—type 2 diabetes mellitus	0.000135	0.000996	CcSEcCtD
Danazol—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000135	0.000992	CcSEcCtD
Danazol—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000133	0.000982	CcSEcCtD
Danazol—Alopecia—Losartan—type 2 diabetes mellitus	0.000132	0.000975	CcSEcCtD
Danazol—Vomiting—Glipizide—type 2 diabetes mellitus	0.000132	0.000971	CcSEcCtD
Danazol—Syncope—Metformin—type 2 diabetes mellitus	0.000132	0.00097	CcSEcCtD
Danazol—Levonorgestrel—SHBG—type 2 diabetes mellitus	0.000132	0.0259	CrCbGaD
Danazol—Oedema—Valsartan—type 2 diabetes mellitus	0.000132	0.00097	CcSEcCtD
Danazol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000131	0.000968	CcSEcCtD
Danazol—Rash—Glipizide—type 2 diabetes mellitus	0.000131	0.000963	CcSEcCtD
Danazol—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000131	0.000962	CcSEcCtD
Danazol—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000131	0.000962	CcSEcCtD
Danazol—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000131	0.000962	CcSEcCtD
Danazol—Oedema—Orlistat—type 2 diabetes mellitus	0.00013	0.000958	CcSEcCtD
Danazol—Headache—Glipizide—type 2 diabetes mellitus	0.00013	0.000957	CcSEcCtD
Danazol—Tremor—Irbesartan—type 2 diabetes mellitus	0.00013	0.000957	CcSEcCtD
Danazol—Palpitations—Metformin—type 2 diabetes mellitus	0.00013	0.000956	CcSEcCtD
Danazol—Shock—Valsartan—type 2 diabetes mellitus	0.00013	0.000954	CcSEcCtD
Danazol—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000129	0.000951	CcSEcCtD
Danazol—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000129	0.000949	CcSEcCtD
Danazol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000129	0.000948	CcSEcCtD
Danazol—Tension—Losartan—type 2 diabetes mellitus	0.000128	0.000943	CcSEcCtD
Danazol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000128	0.000943	CcSEcCtD
Danazol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000128	0.00094	CcSEcCtD
Danazol—Hypertension—Metformin—type 2 diabetes mellitus	0.000127	0.000934	CcSEcCtD
Danazol—Urticaria—Glyburide—type 2 diabetes mellitus	0.000127	0.000934	CcSEcCtD
Danazol—Nervousness—Losartan—type 2 diabetes mellitus	0.000127	0.000933	CcSEcCtD
Danazol—Back pain—Losartan—type 2 diabetes mellitus	0.000126	0.00093	CcSEcCtD
Danazol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000126	0.000929	CcSEcCtD
Danazol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000126	0.000926	CcSEcCtD
Danazol—Fluoxymesterone—SHBG—type 2 diabetes mellitus	0.000126	0.0247	CrCbGaD
Danazol—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000125	0.000924	CcSEcCtD
Danazol—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000125	0.000923	CcSEcCtD
Danazol—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000125	0.000917	CcSEcCtD
Danazol—Headache—Pioglitazone—type 2 diabetes mellitus	0.000124	0.000917	CcSEcCtD
Danazol—Syncope—Irbesartan—type 2 diabetes mellitus	0.000124	0.000916	CcSEcCtD
Danazol—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000124	0.000914	CcSEcCtD
Danazol—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000124	0.000912	CcSEcCtD
Danazol—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000124	0.00091	CcSEcCtD
Danazol—Nausea—Glipizide—type 2 diabetes mellitus	0.000123	0.000907	CcSEcCtD
Danazol—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000123	0.000906	CcSEcCtD
Danazol—Vision blurred—Losartan—type 2 diabetes mellitus	0.000123	0.000906	CcSEcCtD
Danazol—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000123	0.000903	CcSEcCtD
Danazol—Constipation—Gliclazide—type 2 diabetes mellitus	0.000123	0.000903	CcSEcCtD
Danazol—Tremor—Losartan—type 2 diabetes mellitus	0.000122	0.0009	CcSEcCtD
Danazol—Rash—Glimepiride—type 2 diabetes mellitus	0.000122	0.000899	CcSEcCtD
Danazol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000122	0.000898	CcSEcCtD
Danazol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000122	0.000897	CcSEcCtD
Danazol—Rash—Sitagliptin—type 2 diabetes mellitus	0.000122	0.000896	CcSEcCtD
Danazol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000122	0.000895	CcSEcCtD
Danazol—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000122	0.000895	CcSEcCtD
Danazol—Headache—Glimepiride—type 2 diabetes mellitus	0.000121	0.000893	CcSEcCtD
Danazol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000121	0.00089	CcSEcCtD
Danazol—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00012	0.000883	CcSEcCtD
Danazol—Oedema—Metformin—type 2 diabetes mellitus	0.00012	0.000883	CcSEcCtD
Danazol—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00012	0.000882	CcSEcCtD
Danazol—Flushing—Ramipril—type 2 diabetes mellitus	0.000119	0.000878	CcSEcCtD
Danazol—Testosterone Propionate—AR—type 2 diabetes mellitus	0.000119	0.0234	CrCbGaD
Danazol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000119	0.000873	CcSEcCtD
Danazol—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000118	0.000871	CcSEcCtD
Danazol—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000118	0.000869	CcSEcCtD
Danazol—Shock—Metformin—type 2 diabetes mellitus	0.000118	0.000869	CcSEcCtD
Danazol—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000118	0.000866	CcSEcCtD
Danazol—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000117	0.000865	CcSEcCtD
Danazol—Vertigo—Losartan—type 2 diabetes mellitus	0.000117	0.000863	CcSEcCtD
Danazol—Syncope—Losartan—type 2 diabetes mellitus	0.000117	0.000862	CcSEcCtD
Danazol—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000117	0.00086	CcSEcCtD
Danazol—Leukopenia—Losartan—type 2 diabetes mellitus	0.000117	0.00086	CcSEcCtD
Danazol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000116	0.000854	CcSEcCtD
Danazol—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000116	0.000854	CcSEcCtD
Danazol—Levonorgestrel—AR—type 2 diabetes mellitus	0.000115	0.0227	CrCbGaD
Danazol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000115	0.00085	CcSEcCtD
Danazol—Palpitations—Losartan—type 2 diabetes mellitus	0.000115	0.000849	CcSEcCtD
Danazol—Nausea—Glimepiride—type 2 diabetes mellitus	0.000115	0.000847	CcSEcCtD
Danazol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000115	0.000845	CcSEcCtD
Danazol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000115	0.000844	CcSEcCtD
Danazol—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000115	0.000843	CcSEcCtD
Danazol—Asthenia—Glyburide—type 2 diabetes mellitus	0.000115	0.000843	CcSEcCtD
Danazol—Cortisone acetate—NR3C1—type 2 diabetes mellitus	0.000114	0.0224	CrCbGaD
Danazol—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000114	0.000838	CcSEcCtD
Danazol—Alopecia—Ramipril—type 2 diabetes mellitus	0.000114	0.000836	CcSEcCtD
Danazol—Fatigue—Valsartan—type 2 diabetes mellitus	0.000114	0.000836	CcSEcCtD
Danazol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000113	0.000834	CcSEcCtD
Danazol—Oedema—Irbesartan—type 2 diabetes mellitus	0.000113	0.000833	CcSEcCtD
Danazol—Pruritus—Glyburide—type 2 diabetes mellitus	0.000113	0.000832	CcSEcCtD
Danazol—Constipation—Valsartan—type 2 diabetes mellitus	0.000113	0.000829	CcSEcCtD
Danazol—Fatigue—Orlistat—type 2 diabetes mellitus	0.000112	0.000826	CcSEcCtD
Danazol—Shock—Irbesartan—type 2 diabetes mellitus	0.000111	0.00082	CcSEcCtD
Danazol—Arthralgia—Losartan—type 2 diabetes mellitus	0.000111	0.000818	CcSEcCtD
Danazol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000818	CcSEcCtD
Danazol—Ethinyl Estradiol—SHBG—type 2 diabetes mellitus	0.000111	0.0218	CrCbGaD
Danazol—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000111	0.000816	CcSEcCtD
Danazol—Anxiety—Losartan—type 2 diabetes mellitus	0.000111	0.000815	CcSEcCtD
Danazol—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00011	0.000813	CcSEcCtD
Danazol—Rash—Bromocriptine—type 2 diabetes mellitus	0.00011	0.000811	CcSEcCtD
Danazol—Fluoxymesterone—AR—type 2 diabetes mellitus	0.00011	0.0217	CrCbGaD
Danazol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00011	0.00081	CcSEcCtD
Danazol—Tension—Ramipril—type 2 diabetes mellitus	0.00011	0.000809	CcSEcCtD
Danazol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000109	0.000806	CcSEcCtD
Danazol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000806	CcSEcCtD
Danazol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000109	0.000805	CcSEcCtD
Danazol—Nervousness—Ramipril—type 2 diabetes mellitus	0.000109	0.0008	CcSEcCtD
Danazol—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000108	0.000793	CcSEcCtD
Danazol—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000108	0.000792	CcSEcCtD
Danazol—Norethindrone—SHBG—type 2 diabetes mellitus	0.000107	0.021	CrCbGaD
Danazol—Oedema—Losartan—type 2 diabetes mellitus	0.000106	0.000784	CcSEcCtD
Danazol—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000106	0.000777	CcSEcCtD
Danazol—Tremor—Ramipril—type 2 diabetes mellitus	0.000105	0.000772	CcSEcCtD
Danazol—Shock—Losartan—type 2 diabetes mellitus	0.000105	0.000772	CcSEcCtD
Danazol—Urticaria—Valsartan—type 2 diabetes mellitus	0.000105	0.00077	CcSEcCtD
Danazol—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000104	0.000768	CcSEcCtD
Danazol—Tachycardia—Losartan—type 2 diabetes mellitus	0.000104	0.000765	CcSEcCtD
Danazol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000764	CcSEcCtD
Danazol—Fatigue—Metformin—type 2 diabetes mellitus	0.000103	0.000761	CcSEcCtD
Danazol—Urticaria—Orlistat—type 2 diabetes mellitus	0.000103	0.000761	CcSEcCtD
Danazol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000103	0.000759	CcSEcCtD
Danazol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000103	0.000758	CcSEcCtD
Danazol—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000103	0.000757	CcSEcCtD
Danazol—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000103	0.000757	CcSEcCtD
Danazol—Constipation—Metformin—type 2 diabetes mellitus	0.000103	0.000755	CcSEcCtD
Danazol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000102	0.000748	CcSEcCtD
Danazol—Vomiting—Glyburide—type 2 diabetes mellitus	0.000101	0.000747	CcSEcCtD
Danazol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000101	0.000747	CcSEcCtD
Danazol—Methyltestosterone—SHBG—type 2 diabetes mellitus	0.000101	0.0199	CrCbGaD
Danazol—Rash—Glyburide—type 2 diabetes mellitus	0.000101	0.000741	CcSEcCtD
Danazol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000101	0.00074	CcSEcCtD
Danazol—Vertigo—Ramipril—type 2 diabetes mellitus	0.000101	0.00074	CcSEcCtD
Danazol—Syncope—Ramipril—type 2 diabetes mellitus	0.0001	0.000739	CcSEcCtD
Danazol—Leukopenia—Ramipril—type 2 diabetes mellitus	0.0001	0.000738	CcSEcCtD
Danazol—Headache—Glyburide—type 2 diabetes mellitus	0.0001	0.000736	CcSEcCtD
Danazol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.96e-05	0.000734	CcSEcCtD
Danazol—Palpitations—Ramipril—type 2 diabetes mellitus	9.89e-05	0.000728	CcSEcCtD
Danazol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	9.83e-05	0.000724	CcSEcCtD
Danazol—Fatigue—Irbesartan—type 2 diabetes mellitus	9.76e-05	0.000718	CcSEcCtD
Danazol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.7e-05	0.000715	CcSEcCtD
Danazol—Convulsion—Ramipril—type 2 diabetes mellitus	9.69e-05	0.000714	CcSEcCtD
Danazol—Constipation—Irbesartan—type 2 diabetes mellitus	9.68e-05	0.000713	CcSEcCtD
Danazol—Paraesthesia—Losartan—type 2 diabetes mellitus	9.56e-05	0.000704	CcSEcCtD
Danazol—Urticaria—Metformin—type 2 diabetes mellitus	9.53e-05	0.000702	CcSEcCtD
Danazol—Arthralgia—Ramipril—type 2 diabetes mellitus	9.52e-05	0.000702	CcSEcCtD
Danazol—Anxiety—Ramipril—type 2 diabetes mellitus	9.49e-05	0.000699	CcSEcCtD
Danazol—Nausea—Glyburide—type 2 diabetes mellitus	9.48e-05	0.000698	CcSEcCtD
Danazol—Dizziness—Gliclazide—type 2 diabetes mellitus	9.48e-05	0.000698	CcSEcCtD
Danazol—Asthenia—Valsartan—type 2 diabetes mellitus	9.45e-05	0.000696	CcSEcCtD
Danazol—Dyspepsia—Losartan—type 2 diabetes mellitus	9.37e-05	0.00069	CcSEcCtD
Danazol—Asthenia—Orlistat—type 2 diabetes mellitus	9.33e-05	0.000687	CcSEcCtD
Danazol—Pruritus—Valsartan—type 2 diabetes mellitus	9.32e-05	0.000686	CcSEcCtD
Danazol—Pruritus—Orlistat—type 2 diabetes mellitus	9.2e-05	0.000678	CcSEcCtD
Danazol—Fatigue—Losartan—type 2 diabetes mellitus	9.18e-05	0.000676	CcSEcCtD
Danazol—Oedema—Ramipril—type 2 diabetes mellitus	9.13e-05	0.000672	CcSEcCtD
Danazol—Vomiting—Gliclazide—type 2 diabetes mellitus	9.11e-05	0.000671	CcSEcCtD
Danazol—Constipation—Losartan—type 2 diabetes mellitus	9.11e-05	0.000671	CcSEcCtD
Danazol—Rash—Gliclazide—type 2 diabetes mellitus	9.04e-05	0.000665	CcSEcCtD
Danazol—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.03e-05	0.000665	CcSEcCtD
Danazol—Urticaria—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000662	CcSEcCtD
Danazol—Shock—Ramipril—type 2 diabetes mellitus	8.98e-05	0.000662	CcSEcCtD
Danazol—Headache—Gliclazide—type 2 diabetes mellitus	8.98e-05	0.000661	CcSEcCtD
Danazol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000659	CcSEcCtD
Danazol—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.94e-05	0.000658	CcSEcCtD
Danazol—Tachycardia—Ramipril—type 2 diabetes mellitus	8.91e-05	0.000656	CcSEcCtD
Danazol—Methyltestosterone—AR—type 2 diabetes mellitus	8.89e-05	0.0175	CrCbGaD
Danazol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.83e-05	0.00065	CcSEcCtD
Danazol—Dizziness—Valsartan—type 2 diabetes mellitus	8.71e-05	0.000641	CcSEcCtD
Danazol—Ethinyl Estradiol—ABCC2—type 2 diabetes mellitus	8.66e-05	0.017	CrCbGaD
Danazol—Dizziness—Orlistat—type 2 diabetes mellitus	8.6e-05	0.000634	CcSEcCtD
Danazol—Asthenia—Metformin—type 2 diabetes mellitus	8.6e-05	0.000634	CcSEcCtD
Danazol—Nausea—Gliclazide—type 2 diabetes mellitus	8.51e-05	0.000627	CcSEcCtD
Danazol—Pruritus—Metformin—type 2 diabetes mellitus	8.48e-05	0.000625	CcSEcCtD
Danazol—Urticaria—Losartan—type 2 diabetes mellitus	8.46e-05	0.000623	CcSEcCtD
Danazol—Body temperature increased—Losartan—type 2 diabetes mellitus	8.42e-05	0.00062	CcSEcCtD
Danazol—Vomiting—Valsartan—type 2 diabetes mellitus	8.37e-05	0.000617	CcSEcCtD
Danazol—Testosterone—CYP11A1—type 2 diabetes mellitus	8.34e-05	0.0164	CrCbGaD
Danazol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.32e-05	0.000613	CcSEcCtD
Danazol—Rash—Valsartan—type 2 diabetes mellitus	8.3e-05	0.000611	CcSEcCtD
Danazol—Dermatitis—Valsartan—type 2 diabetes mellitus	8.29e-05	0.000611	CcSEcCtD
Danazol—Vomiting—Orlistat—type 2 diabetes mellitus	8.27e-05	0.000609	CcSEcCtD
Danazol—Headache—Valsartan—type 2 diabetes mellitus	8.25e-05	0.000607	CcSEcCtD
Danazol—Rash—Orlistat—type 2 diabetes mellitus	8.2e-05	0.000604	CcSEcCtD
Danazol—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.2e-05	0.000604	CcSEcCtD
Danazol—Dermatitis—Orlistat—type 2 diabetes mellitus	8.2e-05	0.000604	CcSEcCtD
Danazol—Headache—Orlistat—type 2 diabetes mellitus	8.15e-05	0.0006	CcSEcCtD
Danazol—Asthenia—Irbesartan—type 2 diabetes mellitus	8.12e-05	0.000598	CcSEcCtD
Danazol—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.04e-05	0.000592	CcSEcCtD
Danazol—Pruritus—Irbesartan—type 2 diabetes mellitus	8.01e-05	0.00059	CcSEcCtD
Danazol—Dizziness—Metformin—type 2 diabetes mellitus	7.93e-05	0.000584	CcSEcCtD
Danazol—Fatigue—Ramipril—type 2 diabetes mellitus	7.87e-05	0.00058	CcSEcCtD
Danazol—Nausea—Valsartan—type 2 diabetes mellitus	7.82e-05	0.000576	CcSEcCtD
Danazol—Constipation—Ramipril—type 2 diabetes mellitus	7.81e-05	0.000575	CcSEcCtD
Danazol—Nausea—Orlistat—type 2 diabetes mellitus	7.73e-05	0.000569	CcSEcCtD
Danazol—Asthenia—Losartan—type 2 diabetes mellitus	7.64e-05	0.000563	CcSEcCtD
Danazol—Hydrocortisone—SHBG—type 2 diabetes mellitus	7.63e-05	0.015	CrCbGaD
Danazol—Vomiting—Metformin—type 2 diabetes mellitus	7.62e-05	0.000561	CcSEcCtD
Danazol—Rash—Metformin—type 2 diabetes mellitus	7.56e-05	0.000557	CcSEcCtD
Danazol—Dermatitis—Metformin—type 2 diabetes mellitus	7.55e-05	0.000556	CcSEcCtD
Danazol—Pruritus—Losartan—type 2 diabetes mellitus	7.53e-05	0.000555	CcSEcCtD
Danazol—Headache—Metformin—type 2 diabetes mellitus	7.51e-05	0.000553	CcSEcCtD
Danazol—Dizziness—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.000551	CcSEcCtD
Danazol—Fluoxymesterone—NR3C1—type 2 diabetes mellitus	7.46e-05	0.0147	CrCbGaD
Danazol—Urticaria—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000534	CcSEcCtD
Danazol—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000532	CcSEcCtD
Danazol—Vomiting—Irbesartan—type 2 diabetes mellitus	7.19e-05	0.00053	CcSEcCtD
Danazol—Rash—Irbesartan—type 2 diabetes mellitus	7.13e-05	0.000525	CcSEcCtD
Danazol—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.13e-05	0.000525	CcSEcCtD
Danazol—Nausea—Metformin—type 2 diabetes mellitus	7.12e-05	0.000525	CcSEcCtD
Danazol—Headache—Irbesartan—type 2 diabetes mellitus	7.09e-05	0.000522	CcSEcCtD
Danazol—Dizziness—Losartan—type 2 diabetes mellitus	7.04e-05	0.000519	CcSEcCtD
Danazol—Vomiting—Losartan—type 2 diabetes mellitus	6.77e-05	0.000499	CcSEcCtD
Danazol—Nausea—Irbesartan—type 2 diabetes mellitus	6.72e-05	0.000495	CcSEcCtD
Danazol—Rash—Losartan—type 2 diabetes mellitus	6.71e-05	0.000495	CcSEcCtD
Danazol—Dermatitis—Losartan—type 2 diabetes mellitus	6.71e-05	0.000494	CcSEcCtD
Danazol—Headache—Losartan—type 2 diabetes mellitus	6.67e-05	0.000491	CcSEcCtD
Danazol—Cortisone acetate—CYP3A4—type 2 diabetes mellitus	6.61e-05	0.013	CrCbGaD
Danazol—Asthenia—Ramipril—type 2 diabetes mellitus	6.55e-05	0.000482	CcSEcCtD
Danazol—Pruritus—Ramipril—type 2 diabetes mellitus	6.46e-05	0.000476	CcSEcCtD
Danazol—Prednisone—NR3C1—type 2 diabetes mellitus	6.44e-05	0.0127	CrCbGaD
Danazol—Etonogestrel—CYP3A4—type 2 diabetes mellitus	6.42e-05	0.0126	CrCbGaD
Danazol—Nausea—Losartan—type 2 diabetes mellitus	6.33e-05	0.000466	CcSEcCtD
Danazol—Progesterone—SHBG—type 2 diabetes mellitus	6.22e-05	0.0122	CrCbGaD
Danazol—Dizziness—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000445	CcSEcCtD
Danazol—Testosterone—SHBG—type 2 diabetes mellitus	5.88e-05	0.0116	CrCbGaD
Danazol—Vomiting—Ramipril—type 2 diabetes mellitus	5.81e-05	0.000428	CcSEcCtD
Danazol—Rash—Ramipril—type 2 diabetes mellitus	5.76e-05	0.000424	CcSEcCtD
Danazol—Dermatitis—Ramipril—type 2 diabetes mellitus	5.75e-05	0.000424	CcSEcCtD
Danazol—Headache—Ramipril—type 2 diabetes mellitus	5.72e-05	0.000421	CcSEcCtD
Danazol—Progesterone—AR—type 2 diabetes mellitus	5.45e-05	0.0107	CrCbGaD
Danazol—Nausea—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000399	CcSEcCtD
Danazol—Testosterone—AR—type 2 diabetes mellitus	5.15e-05	0.0101	CrCbGaD
Danazol—Levonorgestrel—CYP3A4—type 2 diabetes mellitus	4.54e-05	0.00893	CrCbGaD
Danazol—Hydrocortisone—NR3C1—type 2 diabetes mellitus	4.54e-05	0.00893	CrCbGaD
Danazol—Ethinyl Estradiol—CYP3A4—type 2 diabetes mellitus	3.83e-05	0.00753	CrCbGaD
Danazol—Prednisone—CYP3A4—type 2 diabetes mellitus	3.73e-05	0.00734	CrCbGaD
Danazol—Progesterone—NR3C1—type 2 diabetes mellitus	3.7e-05	0.00728	CrCbGaD
Danazol—Norethindrone—CYP3A4—type 2 diabetes mellitus	3.68e-05	0.00724	CrCbGaD
Danazol—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	3.49e-05	0.00687	CrCbGaD
Danazol—Prednisone—ALB—type 2 diabetes mellitus	3.26e-05	0.00641	CrCbGaD
Danazol—Progesterone—CYP1A2—type 2 diabetes mellitus	3.24e-05	0.00637	CrCbGaD
Danazol—Norethindrone—ALB—type 2 diabetes mellitus	3.21e-05	0.00631	CrCbGaD
Danazol—Methyltestosterone—ALB—type 2 diabetes mellitus	3.05e-05	0.006	CrCbGaD
Danazol—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	2.63e-05	0.00518	CrCbGaD
Danazol—Progesterone—CYP3A4—type 2 diabetes mellitus	2.14e-05	0.00422	CrCbGaD
Danazol—Testosterone—CYP3A4—type 2 diabetes mellitus	2.03e-05	0.00399	CrCbGaD
Danazol—Testosterone—ALB—type 2 diabetes mellitus	1.77e-05	0.00348	CrCbGaD
Danazol—PGR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.13e-06	9.26e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	9.02e-06	9.15e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP2E1—type 2 diabetes mellitus	8.96e-06	9.09e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AR—type 2 diabetes mellitus	8.94e-06	9.07e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOB—type 2 diabetes mellitus	8.9e-06	9.03e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.86e-06	9e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.86e-06	9e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.85e-06	8.99e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.85e-06	8.99e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	8.83e-06	8.96e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—PPARA—type 2 diabetes mellitus	8.79e-06	8.93e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.76e-06	8.89e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RELA—type 2 diabetes mellitus	8.71e-06	8.84e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP3A4—type 2 diabetes mellitus	8.64e-06	8.76e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—SERPINE1—type 2 diabetes mellitus	8.6e-06	8.72e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	8.59e-06	8.72e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LPL—type 2 diabetes mellitus	8.5e-06	8.62e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GCG—type 2 diabetes mellitus	8.49e-06	8.62e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.49e-06	8.62e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.46e-06	8.59e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.46e-06	8.59e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.32e-06	8.44e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—CDKN2B—type 2 diabetes mellitus	8.24e-06	8.36e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	8.17e-06	8.29e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SIRT1—type 2 diabetes mellitus	8.15e-06	8.27e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	8.12e-06	8.24e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—INSR—type 2 diabetes mellitus	8.07e-06	8.19e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.97e-06	8.09e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RELA—type 2 diabetes mellitus	7.96e-06	8.08e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	7.93e-06	8.05e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	7.88e-06	8e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.85e-06	7.97e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.83e-06	7.95e-05	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.8e-06	7.92e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	7.72e-06	7.84e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	7.72e-06	7.84e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—C3—type 2 diabetes mellitus	7.65e-06	7.76e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	7.55e-06	7.66e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.42e-06	7.53e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.34e-06	7.45e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	7.33e-06	7.44e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	7.33e-06	7.44e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	7.32e-06	7.43e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	7.32e-06	7.43e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GNB3—type 2 diabetes mellitus	7.32e-06	7.43e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.32e-06	7.43e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.3e-06	7.41e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HMOX1—type 2 diabetes mellitus	7.28e-06	7.39e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.28e-06	7.39e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—PPARG—type 2 diabetes mellitus	7.27e-06	7.38e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AGT—type 2 diabetes mellitus	7.27e-06	7.38e-05	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.25e-06	7.36e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NR3C1—type 2 diabetes mellitus	7.23e-06	7.34e-05	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.2e-06	7.31e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPP2CA—type 2 diabetes mellitus	7.2e-06	7.3e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CAT—type 2 diabetes mellitus	7.19e-06	7.29e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.18e-06	7.29e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.15e-06	7.25e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.14e-06	7.24e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	7.13e-06	7.24e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LEP—type 2 diabetes mellitus	7.12e-06	7.23e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—type 2 diabetes mellitus	7.12e-06	7.23e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	7.1e-06	7.2e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.04e-06	7.15e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	6.98e-06	7.09e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	6.98e-06	7.08e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOB—type 2 diabetes mellitus	6.98e-06	7.08e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	6.95e-06	7.05e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	6.95e-06	7.05e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	6.86e-06	6.97e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SRC—type 2 diabetes mellitus	6.84e-06	6.95e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.79e-06	6.89e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTM1—type 2 diabetes mellitus	6.79e-06	6.89e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARA—type 2 diabetes mellitus	6.77e-06	6.88e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.72e-06	6.82e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.72e-06	6.82e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.66e-06	6.76e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—LPL—type 2 diabetes mellitus	6.66e-06	6.76e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.58e-06	6.68e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—SERPINE1—type 2 diabetes mellitus	6.55e-06	6.65e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ADCY5—type 2 diabetes mellitus	6.52e-06	6.62e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GPX1—type 2 diabetes mellitus	6.5e-06	6.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	6.46e-06	6.56e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	6.44e-06	6.54e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	6.44e-06	6.54e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GCG—type 2 diabetes mellitus	6.35e-06	6.45e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	6.35e-06	6.45e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.35e-06	6.45e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CD36—type 2 diabetes mellitus	6.33e-06	6.42e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SRC—type 2 diabetes mellitus	6.26e-06	6.35e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	6.25e-06	6.35e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.25e-06	6.34e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	6.23e-06	6.33e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	6.22e-06	6.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	6.22e-06	6.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	6.22e-06	6.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	6.22e-06	6.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	6.22e-06	6.32e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.12e-06	6.21e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.1e-06	6.19e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—INS—type 2 diabetes mellitus	6.08e-06	6.18e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	6.03e-06	6.12e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	6e-06	6.09e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6e-06	6.09e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.99e-06	6.08e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.89e-06	5.97e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	5.88e-06	5.97e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.88e-06	5.97e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	5.7e-06	5.78e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	5.69e-06	5.78e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	5.69e-06	5.78e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	5.6e-06	5.69e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARG—type 2 diabetes mellitus	5.6e-06	5.68e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.59e-06	5.68e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.59e-06	5.67e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	5.58e-06	5.67e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	5.55e-06	5.63e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	5.53e-06	5.61e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	5.52e-06	5.6e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.49e-06	5.57e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	5.48e-06	5.56e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AVP—type 2 diabetes mellitus	5.4e-06	5.48e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.4e-06	5.48e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.38e-06	5.46e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.36e-06	5.44e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.34e-06	5.42e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.34e-06	5.42e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	5.29e-06	5.37e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	5.29e-06	5.37e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	5.29e-06	5.37e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOB—type 2 diabetes mellitus	5.22e-06	5.3e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.2e-06	5.28e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.14e-06	5.22e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.07e-06	5.15e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.07e-06	5.15e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SERPINE1—type 2 diabetes mellitus	5.04e-06	5.12e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RELA—type 2 diabetes mellitus	5.02e-06	5.1e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LPL—type 2 diabetes mellitus	4.99e-06	5.06e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	4.88e-06	4.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	4.88e-06	4.96e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.88e-06	4.96e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	4.86e-06	4.94e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.8e-06	4.87e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	4.77e-06	4.84e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.72e-06	4.79e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.72e-06	4.79e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.72e-06	4.79e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.68e-06	4.75e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.61e-06	4.68e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.59e-06	4.66e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.53e-06	4.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—C3—type 2 diabetes mellitus	4.49e-06	4.56e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.43e-06	4.5e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	4.37e-06	4.44e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.28e-06	4.35e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.28e-06	4.34e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.27e-06	4.34e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.27e-06	4.33e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.25e-06	4.32e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.24e-06	4.3e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—type 2 diabetes mellitus	4.22e-06	4.28e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.19e-06	4.26e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	4.18e-06	4.25e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.18e-06	4.25e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.18e-06	4.24e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.18e-06	4.24e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.15e-06	4.21e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.13e-06	4.19e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.01e-06	4.07e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.01e-06	4.07e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.01e-06	4.07e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.01e-06	4.07e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SRC—type 2 diabetes mellitus	3.95e-06	4.01e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.94e-06	4e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.89e-06	3.95e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.84e-06	3.9e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.84e-06	3.9e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	3.83e-06	3.88e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—type 2 diabetes mellitus	3.77e-06	3.83e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.73e-06	3.78e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.57e-06	3.63e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—INS—type 2 diabetes mellitus	3.57e-06	3.62e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.53e-06	3.58e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.51e-06	3.57e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.46e-06	3.51e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.45e-06	3.51e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.45e-06	3.5e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.34e-06	3.39e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.28e-06	3.33e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.27e-06	3.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.27e-06	3.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.21e-06	3.25e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.19e-06	3.23e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.19e-06	3.23e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.19e-06	3.23e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.17e-06	3.21e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.13e-06	3.18e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.13e-06	3.18e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.11e-06	3.16e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.07e-06	3.12e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.95e-06	2.99e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—type 2 diabetes mellitus	2.87e-06	2.92e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.86e-06	2.9e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.86e-06	2.9e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.86e-06	2.9e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.8e-06	2.85e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.78e-06	2.82e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.72e-06	2.76e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.66e-06	2.7e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—type 2 diabetes mellitus	2.66e-06	2.7e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.61e-06	2.65e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.58e-06	2.62e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.58e-06	2.62e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.51e-06	2.55e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.49e-06	2.52e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.48e-06	2.51e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.48e-06	2.51e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.45e-06	2.49e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.32e-06	2.35e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.26e-06	2.29e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—type 2 diabetes mellitus	2.21e-06	2.25e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.14e-06	2.17e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.14e-06	2.17e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.13e-06	2.16e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.1e-06	2.13e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.07e-06	2.1e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.04e-06	2.07e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.03e-06	2.06e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.98e-06	2.01e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.94e-06	1.97e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	1.92e-06	1.95e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.9e-06	1.93e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.9e-06	1.93e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.85e-06	1.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.82e-06	1.85e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.75e-06	1.78e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.72e-06	1.74e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.66e-06	1.69e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.64e-06	1.66e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.63e-06	1.65e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.61e-06	1.63e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.56e-06	1.58e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.44e-06	1.46e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.42e-06	1.44e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.39e-06	1.41e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.28e-06	1.3e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.22e-06	1.24e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.22e-06	1.24e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.12e-06	1.13e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.61e-07	5.7e-06	CbGpPWpGaD
